NCT05389358

Brief Summary

This quasi-experimental feasibility study recruit n=40 participants from each of two public antenatal clinics in Johannesburg, South Africa. Using the Bowen et al. approach, key feasibility study questions will be those around acceptability, implementation, and promising effects on intermediate variable. While this pilot trial is not powered to determine efficacy, it can help establish whether intervention targets the appropriate intermediate mechanisms (i.e. primary endpoints of IPV exposure and depressive symptoms) and moves intended outcomes in the right direction (i.e. towards better adherence as measured by self-reported adherence).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2022

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 26, 2022

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

May 16, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 25, 2022

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

May 25, 2022

Status Verified

May 1, 2022

Enrollment Period

1.9 years

First QC Date

May 16, 2022

Last Update Submit

May 19, 2022

Conditions

Keywords

intimate partner violenceperinatal depressionART adherenceHIVantenatal careprevention of mother-to-child transmission

Outcome Measures

Primary Outcomes (2)

  • Depression

    Depressive symptoms using Patient Health Questionnaire-9 will be assessed as a continuous marker of symptomology (with ≥13 indicating probable depression)

    6 months postpartum

  • Intimate partner violence

    IPV exposure will be measured using the World Health Organization multicountry study instrument of behaviorally-specific likert-type items about frequency of physical, sexual, or psychological violence from a partner. Any IPV will be defined as an affirmative response to any physical, sexual, or psychological violence question. For primary outcome assessment, the WHO instrument will be examined as a continuous measure summing all standardized response items as a marker of IPV intensity (Tsai, 2016).

    6 months postpartum

Secondary Outcomes (1)

  • ART adherence

    6 months postpartum

Other Outcomes (3)

  • Viral suppression

    6 months postpartum

  • Anxiety

    6 months postpartum

  • PTSD

    6 months postpartum

Study Arms (2)

Intervention

EXPERIMENTAL

The Asiphephe (meaning "Let us stay safe") intervention is a problem-solving therapy manual delivered in a one-on-one setting by lay health workers during routine antenatal care. Lay health workers are already employed by the Department of Health and are trained in-service (30 hours) and receive monthly supervision (total of approximately 6 one-on-one hours; 15 group hours). Asiphephe includes illustrated job aids, participant workbook, intervention checklist, and an intervention manual. The model is informed by problem-solving therapy (Lund, 2018), trauma-informed coping (Sikkema, 2018) and safety planning (Garcia-Moreno, forthcoming) and was piloted with 12 health workers with input from 3 global mental health experts.

Behavioral: Asiphephe health worker trainingBehavioral: Asiphephe therapeutic sessionsOther: IPV assessmentOther: Referral for IPV or Mental Health

Enhanced standard of care

ACTIVE COMPARATOR

The enhanced standard of care condition will entail a clinic-wide training (5 hours) on IPV, mental health, and HIV care in order to sensitize staff to the nature of the research. The clinic will receive access to established referral network to which participants can gain additional help with violence exposure or mental ill health. Participants in this arm will also be observed for adverse events and social harms, with referrals made appropriately by study staff.

Other: IPV assessmentOther: Referral for IPV or Mental Health

Interventions

Lay health workers are already employed by the Department of Health and are trained in-service (30 hours) and receive monthly supervision (total of approximately 6 one-on-one hours; 15 group hours).

Intervention

Asiphephe sessions are manualized using illustrated job aids, a participant workbook, session checklists, and an intervention manual. The model is informed by problem-solving therapy (Lund, 2018), trauma-informed coping (Sikkema, 2018) and safety planning (Garcia-Moreno, forthcoming) and was piloted with 12 health workers with input from 3 global mental health experts.

Intervention

IPV intensity as measured by WHO Multicountry Study Instrument at a cut-off of any past-year physical/sexual/psychological violence exposure vs. none

Enhanced standard of careIntervention

Study staff are trained to recognize signs or symptoms of distress and to make appropriate referrals to appropriate community-based services, if necessary. Experienced mental health professionals on the investigative can be consulted or referred to should a participant exhibit severe symptom of mental distress.

Enhanced standard of careIntervention

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older (the age of research consent in South Africa)
  • currently pregnant and less than 30 weeks gestation (from antenatal green card)
  • speak a study language (English, isiZulu, Sesotho)
  • living with HIV (self-reported and confirmed on green card)
  • report past-year IPV (score of ≥1 on WHO multicountry study instrument)
  • are willing to provide informed consent

You may not qualify if:

  • at risk of immediate danger (current suicidality, homicidality, or risk to child safety)
  • planning to terminate the pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Malvern Clinic

Johannesburg, Gauteng, 2094, South Africa

RECRUITING

Yeoville Clinic

Johannesburg, Gauteng, 2198, South Africa

NOT YET RECRUITING

MeSH Terms

Conditions

DepressionMedication Adherence

Interventions

Referral and ConsultationPoliovirus Vaccine, InactivatedMental Health

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorPatient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth Behavior

Intervention Hierarchy (Ancestors)

Professional PracticeOrganization and AdministrationHealth Services AdministrationVaccines, InactivatedVaccinesBiological ProductsComplex MixturesPoliovirus VaccinesViral VaccinesHealthPopulation Characteristics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participants at routine antenatal care will not know whether their clinic is the intervention or enhanced usual care arm, since both will offer support that is over-and-above standard care. Outcomes will be assessed using self-completed tablet computers, so there is no outcomes assessor.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: 2 primary health clinics offering antenatal care services in inner-city Johannesburg, South Africa will be randomized to receive intervention or enhanced standard of care. Within each clinic n=40 participants will take part in baseline, midline, and endline assessments.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 16, 2022

First Posted

May 25, 2022

Study Start

April 26, 2022

Primary Completion

March 31, 2024

Study Completion

June 30, 2024

Last Updated

May 25, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

The pilot nature of this study and small sample mean we will not make IDP available to researchers outside of our investigative team.

Locations